NEW YORK, Aug. 8 – CombiMatrix will see its microarrays launched into space in a deal with NASA Ames Research Center, the company announced on Wednesday.

The National Aeronautics and Space Administration has agreed to license and purchase CombiMatrix’s active biochips and technology to use in biological research in ground-based labs and aboard the International Space Station. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.